脑机接口（BCI）服务价格话题再引行业关注。 据央视新闻报道，为支持药品和医疗器械创新发展，国家医保局制定新上市药品首发价格机制，新增了 100多项与医疗新技术相关的价格项目。其中，神经系统类立项指南统一设立"脑机接口置入费""脑机接 口适配费"等价格项目，脑机接口技术成熟获批进入临床后，可快速进入临床应用并收费。 目前，湖北、浙江、江苏已发布相关服务价格。上海市卫生和健康发展研究中心主任金春林向21世纪经 济报道记者表示，2025年可以说是脑机接口技术爆发的元年，但是要想大规模落地，还需要5至8年的时 间。国家医保局为脑机接口设立的置入费、取出费和适配费，将有效推动该技术的临床应用进程，同时 能增强资本市场对脑机接口领域的投资信心，进而促进产业链上下游的协同发展，加速形成良性循环的 产业生态。 谈及相关价格的设立对未来脑机接口被纳入医保有何影响，首都医科大学国家医保研究院原副研究员仲 崇明向21世纪经济报道记者表示，医疗服务价格改革体系的核心目标之一，是支持临床创新、满足医患 脑机接口是在大脑与外部设备之间创建信息通道，实现两者之间直接信息交互的新型交叉技术。根据硬 件接入方式的不同，脑机接口可分为侵入式、 ...

Group 1 - The pharmaceutical and biotechnology industry is experiencing rapid development supported by policies, with the innovative drug sector entering a commercialization phase [1] - In 2024, many companies are expected to significantly reduce losses, with high research and development enthusiasm for dual/multi-antibody drugs, ADCs, and gene therapies [1] - The medical device sector is seeing structural differentiation, with significant growth in bidding for medical devices expected in Q1 2025, particularly in medical imaging equipment, which is projected to grow over 85% [1] Group 2 - Policy documents such as "Opinions on Deepening the Reform of Drug and Medical Device Regulation to Promote High-Quality Development of the Pharmaceutical Industry" have been released, optimizing review and approval processes to support innovation [1] - The brain-computer interface and other new technologies are becoming important growth drivers, with national and local policies promoting their standardized development [1] - The traditional Chinese medicine sector is revitalizing through digital transformation, with new business models emerging under the "Traditional Chinese Medicine +" concept, and the potential for health consumption continues to be released [1] Group 3 - The industry as a whole benefits from an aging population, increased health awareness among residents, and policy dividends, although attention should be paid to risks such as centralized procurement price reductions and international competition [1] - The ChiNext Medical ETF tracks the ChiNext Medical Index, which is compiled by China Securities Index Co., Ltd., selecting listed companies in the biopharmaceutical, medical device, and medical service sectors from the ChiNext market to reflect the overall performance of high-growth, innovative enterprises [1]